- Public regulatory, randomized-trial, guideline, surgical-cohort, ECMO-context, and transplant-consensus sources were identified within their stated scopes.
- An authorized hospital-specific aggregate dataset for the index cohort
- Hospital-level exposure, follow-up, survival, adverse-event, or patient-feedback outcomes for this case
- Peer-reviewed hospital aggregate study
- Public registry analysis with cohort and censoring definitions
- Authorized de-identified aggregate report with reuse terms
- Patient-identifiable data
- Anecdotes
- Hospital marketing claims
- Aggregate numbers without cohort or outcome definitions
GAP_ID
OEG-ONC-001
CASE_ID
SE-ONC-NSQNSCLC-CN-001
CLAIM
A hospital-specific aggregate outcome dataset has been acquired for this public NSCLC case.
CURRENT STATE
NOT_ESTABLISHED
SCOPE
China non-squamous NSCLC; the detailed index cohort is EGFR-mutated locally advanced or metastatic disease after EGFR-TKI progression.
EVIDENCE CUTOFF
2026-09-28
WHAT IS ESTABLISHED
WHAT IS NOT ESTABLISHED
WHAT WOULD CHANGE THIS
A lawful public aggregate dataset or citable public analysis with a defined hospital population, cohort criteria, treatment exposure, outcome definitions, follow-up, censoring, and permitted reuse boundary.
ACCEPTABLE SOURCES
NON-QUALIFYING SOURCES